BUSINESS

• FY2015 Earnings Roundup - 5: 10 Firms Unveil Mid-Term Biz Plans, Many Play It Safe
  June 10, 2016

• Mitsubishi Gas Chemical, Nippon Kayaku Form JV for Antibody, Biosimilar Production
  June 10, 2016

• Takeda Gets Worldwide Rights to Theravance’s GI Drug Candidate
  June 10, 2016

• Jacques Nathan to Lead Sanofi Japan from July 1
  June 10, 2016

• AZ Japan Pres. Baertschi to Become CEO of Grünenthal in October
  June 9, 2016

• Takeda, Ultragenyx Ink Strategic Partnership on Rare Genetic Diseases
  June 9, 2016

• Shionogi to Transfer 3 Off-Patent Cancer Drugs to Nichi-Iko
  June 9, 2016

• FY2015 Earnings Roundup - 4: Generic Biz Strategies Revolving around AG Launches
  June 9, 2016

• Kaketsuken Announces Plan for Production Restart, Says Flu Vaccine Output Will Be Lower
  June 9, 2016

• Kyowa Kirin, Medgenics Team Up on Severe Pediatric IBD Treatment
  June 8, 2016

• FY2015 Earnings Roundup - 3: Japan Market Stagnates despite No Drug Price Revision, Off-Patent Brands Weigh
  June 8, 2016

• Takeda, Roivant Form Joint Venture for Women’s Health, Prostate Cancer; Takeda Transfers 2 Investigational Products
  June 8, 2016

• FY2015 Earnings Roundup - 2: New Drugs Gain Traction Overseas to Underpin Japan Makers’ Financial Results
  June 7, 2016

• PDUFA Date for Naldemedine Set for March 23, 2017
  June 7, 2016

• Takecab Most Promoted Drug for 4 Months on End: Anterio
  June 7, 2016

• FY2015 Earnings Roundup - 1: Operating Profits of Japan Makers Climb on Global Brands, Royalties
  June 6, 2016

• Eisai, Novartis to Join Forces in US Lenvima Promotion for Kidney Cancer
  June 6, 2016

• Astellas to Kick Off Global PIII on Xtandi for Triple-Negative Breast Cancer
  June 6, 2016

• 27 Japan Drug Makers Derive Record 45.8% of Sales from Overseas Market: Jiho Tally
  June 3, 2016

• AbbVie, EA Pharma Initiate Copromotion of Humira in GI Field
  June 3, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 479
• 480
• 481
• 482
• 483
• 484
• 485
• 486
• 487
• …
• Next ›
• 最終 »